Adma Biologics | ADMA - Sales Revenues

Name: Adma Biologics | ADMA - Sales Revenues
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Adma,Biologics,ADMA,Sales,Revenues,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

Adma Biologics

Adma Biologics reported $56.91M in Sales Revenues for its fiscal quarter ending in March of 2023.

	Sales		Date
Adamis Pharmaceuticals ADMP:US	USD 1.45M	697.68K	Mar/2023
Adma Biologics ADMA:US	USD 56.91M	6.93M	Mar/2023
Agile Therapeutics AGRX:US	USD 3.81M	183K	Mar/2023
Alnylam Pharmaceuticals ALNY:US	USD 319.29M	15.74M	Mar/2023
BioCryst Pharmaceuticals BCRX:US	USD 68.78M	10.77M	Mar/2023
Dynavax Technologies DVAX:US	USD 46.92M	137.57M	Mar/2023
Novavax NVAX:US	USD 80.95M	276.45M	Mar/2023
Takeda 4502:JP	JPY 956.16B	140.4B	Mar/2023